CEL-SCI CORPORATION Increase (Decrease) in Deposit Assets
CEL-SCI CORPORATION (CVM) reported Increase (Decrease) in Deposit Assets of $3.58 thousand for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositOtherAssets · last filed 2025-12-29
- CEL-SCI CORPORATION increase (decrease) in deposit assets for the quarter ending 2011-09-30 was -$1.67M, a 16591.48% decline year-over-year.
- CEL-SCI CORPORATION increase (decrease) in deposit assets for the quarter ending 2010-09-30 was $10.13K.
- CEL-SCI CORPORATION increase (decrease) in deposit assets for fiscal 2025 was $3.58K.
- CEL-SCI CORPORATION increase (decrease) in deposit assets for fiscal 2024 was -$745.00, a 100.03% decline from fiscal 2023.
- CEL-SCI CORPORATION increase (decrease) in deposit assets for fiscal 2023 was $2.32M.
- CEL-SCI CORPORATION increase (decrease) in deposit assets for fiscal 2011 was -$1.67M, a 205.42% decline from fiscal 2010.
| Period end | Increase (Decrease) in Deposit Assets 3 month | Increase (Decrease) in Deposit Assets 9 month | Increase (Decrease) in Deposit Assets 12 month |
|---|---|---|---|
| 2025-09-30 | $3.58K 10-K · filed 2025-12-29 | ||
| 2024-09-30 | -$745.00 10-K · filed 2025-12-29 | ||
| 2023-09-30 | $2.32M 10-K · filed 2025-01-13 | ||
| 2011-09-30 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-23 | -$1.67M 10-K · filed 2011-12-23 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | ||
| 2010-09-30 | $10.13K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-23 | $1.59M 10-K · filed 2011-12-23 | |
| 2010-06-30 | $1.57M 10-Q · filed 2011-08-09 | ||
| 2009-09-30 | $4.76K 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |